ASCEND BY NTHRYS
Research Abroad Products

Drug Designing Project Topics

Browse all focused areas across all project categories under this field.

Showing 241–252 of 280 project topics
Lysosomal Storage Disease Enzyme Replacement
Producing and characterizing recombinant lysosomal enzymes for enzyme replacement therapy in Gaucher, Pompe, and Fabry diseases with optimized glycosylation for cellular uptake.
Therapeutic Enzyme Development Click to view more details →
Thrombolytic Enzyme Engineering for Stroke Treatment
Engineering improved tissue plasminogen activator and streptokinase variants with extended half-life and improved clot selectivity for acute ischemic stroke and myocardial infarction treatment.
Therapeutic Enzyme Development Click to view more details →
Therapeutic DNase for Cystic Fibrosis Treatment
Producing recombinant DNase I and developing optimized formulations for inhalation delivery to reduce sputum viscosity and improve lung function in cystic fibrosis patients.
Therapeutic Enzyme Development Click to view more details →
Uricase Engineering for Gout Treatment
Engineering polyethylene glycol-modified recombinant uricase with reduced immunogenicity and improved pharmacokinetics for developing improved treatments for refractory gout.
Therapeutic Enzyme Development Click to view more details →
Protease Platform for Wound Healing and Tissue Regeneration
A commercial enzyme platform delivering engineered proteases that accelerate debridement and promote tissue remodeling in chronic wound management. This generates recurring revenue through licensing agreements with wound care manufacturers and direct sales to hospital systems seeking advanced therapeutic solutions.
Therapeutic Enzyme Development Click to view more details →
Lactase Production SaaS for Personalized Dairy Tolerance Solutions
A B2B SaaS platform optimizing lactase enzyme formulation and delivery for nutraceutical companies targeting lactose-intolerant populations globally. The platform monetizes through subscription licensing, ingredient supply agreements, and performance-based royalties on end-consumer products.
Therapeutic Enzyme Development Click to view more details →
Amylase Enzyme Engineering Suite for Starch Processing Industries
An industrial biotechnology tool enabling real-time enzyme optimization for glucose syrup, bioethanol, and food ingredient manufacturers to maximize yield efficiency. Revenue streams include licensing fees, process optimization consulting, and enzyme bulk supply partnerships with major food and beverage corporations.
Therapeutic Enzyme Development Click to view more details →
Cellulase-Based Biofuel Conversion Service for Renewable Energy
A commercial enzyme service converting agricultural waste into bioethanol and biochemicals through engineered cellulase complexes optimized for industrial scale. This delivers revenue through per-ton processing fees, energy production licensing, and carbon credit monetization for sustainable fuel production.
Therapeutic Enzyme Development Click to view more details →
Phosphatase Diagnostic Enzyme Kit for Clinical Laboratory Automation
A ready-to-deploy enzyme reagent system for automated clinical analyzers measuring bone metabolism and liver function markers with superior specificity. The business model generates high-margin recurring revenue through consumable kit sales, analyzer integration partnerships, and lab certification programs.
Therapeutic Enzyme Development Click to view more details →
Collagenase Bioreactor Platform for Regenerative Medicine Manufacturing
An automated bioreactor and enzyme delivery platform for large-scale production of cell therapy and tissue engineering products requiring controlled collagen remodeling. Revenue is derived through equipment leasing, process licensing to contract manufacturers, and milestone payments from regenerative medicine companies.
Therapeutic Enzyme Development Click to view more details →
PLGA Microsphere Preparation for Protein Delivery
Developing double emulsion and spray drying methods for encapsulating proteins and peptides in PLGA microspheres for sustained release depot formulations reducing dosing frequency.
Biodegradable Drug Delivery Biotechnology Click to view more details →
Hydrogel Depot Formulation for Controlled Release
Formulating thermosensitive and photocrosslinkable hydrogel depot systems for subcutaneous injection providing weeks-to-months sustained drug release from a single administration.
Biodegradable Drug Delivery Biotechnology Click to view more details →